Dental Membrane and Bone Graft Substitute Market Size, Share, Trends, Growth 2032

Dental Membrane and Bone Graft Substitute Industry Prospective:

The global dental membrane and bone graft substitute market size was worth around USD 1,100 million in 2023 and is predicted to grow to around USD 2,500 million by 2032, with a compound annual growth rate (CAGR) of roughly 9.3% between 2024 and 2032.

Request Free Sample

Dental Membrane and Bone Graft Substitute Market: Overview

Dental membrane and bone graft substitutes are medical products used in oral and maxillofacial surgery, specifically in procedures meant to regenerate or repair bone and tissue. In periodontal surgery, dental implantology, and other regenerative therapies, these goods are quite useful. Systems of guided tissue and guided bone regeneration (GBR) use dental membranes as barrier materials.

Moreover, materials known as bone graft replacements help to augment or replace damaged or destroyed bone tissue. The dental membrane and bone graft substitute market is driven by several variables, such as the growing prevalence of dental disorders, growing adoption of dental implants, increased awareness & accessibility, and others. However, the high cost of materials and procedures hamper the dental membrane and bone graft substitute industry expansion.

Key Insights

• As per the analysis shared by our research analyst, the global dental membrane and bone graft substitute market is estimated to grow annually at a CAGR of around 9.3% over the forecast period (2024-2032).
• In terms of revenue, the global dental membrane and bone graft substitute market size was valued at around USD 1,100 million in 2023 and is projected to reach USD 2,500 million by 2032.
• The increasing prevalence of dental disorders is expected to drive the dental membrane and bone graft substitute market over the forecast period.
• Based on the product type, the bone graft substitutes segment is expected to dominate the market over the forecast period.
• Based on the material type, the collagen segment is expected to hold the largest market share over the forecast period.
• Based on the end users, the dental clinics segment is expected to hold the largest market share over the forecast period.
• Based on region, North America is expected to dominate the market during the forecast period.

Dental Membrane and Bone Graft Substitute Market: Growth Drivers

Rising dental disorder drives market growth

One of the main forces behind the growth in the market for bone grafts and dental membrane replacements is the increasing frequency of dental problems. Rising edentulism and tooth loss brought on by periodontal diseases have driven up the worldwide count of dental implant surgeries. Nowadays, membranes and bone replacements are more important to guarantee the lifetime and success of implants.

Furthermore, early diagnosis of dental issues and the availability of diagnostic equipment have boosted awareness of oral health, therefore enabling quick intervention with regenerative treatments. The World Health Organization estimates, for instance, that 2 billion individuals globally suffer from persistent tooth caries, and 514 million children worldwide suffer from primary tooth caries.

Dental Membrane and Bone Graft Substitute Market: Restraints

Lack of skilled professionals hinders market growth

Since dental membranes and bone graft substitutes require sophisticated skills for proper application, the shortage of qualified experts is a major barrier to the dental membrane and bone graft substitute market. Both bone grafting and guided tissue regeneration (GTR) require accuracy and a specific understanding of surgical methods, material handling, and anatomical features. Insufficient instruction or experience may result in graft failures, procedural mistakes, or less than ideal results.

Continuous education and training are also necessary for the introduction of novel materials, such as bioactive and custom 3D-printed grafts. Those in the dental field who are not familiar with these developments might be reluctant to use them.

Dental Membrane and Bone Graft Substitute Market: Opportunities

The introduction of advanced bone graft substitutes offers a lucrative opportunity for market growth

The expanding prevalence of dental problems has increased the need for novel bone graft alternatives, such as allografts and synthetic bone grafts. The increasing number of dental implants that use bone graft replacements will drive up demand for these products. As a result, market players are focusing more on producing sophisticated bone transplant replacements.

In February 2024, for instance, Geistlich Pharma AG introduced the vallos granules. Demineralized allografts can be used for a variety of purposes, including dental operations. These advances are expected to increase the need for alternatives to dental bone transplantation. Throughout the projected period, an increasing number of clinical trials and regulatory body approvals are likely to encourage the development of new products and the acceptance of dental bone graft substitutes in a wide range of geographies and applications.

For instance, in June 2023, RevBio, Inc. obtained a USD 2 million Phase II Small Business Innovation Research (SBIR) funding from the US National Institutes of Health (NIH) to help develop their dental adhesive bone scaffold product for clinical use. These factors are projected to drive future dental membrane and bone graft substitute industry growth.

Dental Membrane and Bone Graft Substitute Market: Challenges

Clinical limitation and limited reimbursement pose a major challenge to market expansion

The dental membrane and bone graft substitute market is experiencing several breakthroughs and product introductions around the world. However, there are several limitations to their usefulness based on clinical evidence, as well as limited funding for dental procedures. The market may encounter problems as a result of potential side effects of these alternatives, including unfavorable tissue reactions, insufficient bone growth, and lack of effectiveness.

Furthermore, worries about disease transmission, immunogenicity, slow resorption rates, low mechanical strength, and insufficient osteoinductive qualities may limit the market's future growth.

Furthermore, problems in assessing in-vivo and clinical trial outcomes, as well as the execution of strict regulatory rules, may impede market expansion. Furthermore, in some countries, oral bone graft substitutes are not covered by insurance or are inadequately reimbursed. The high out-of-pocket expenses may prevent patients from undergoing these operations, limiting demand for these items.

Dental Membrane and Bone Graft Substitute Market: Report Scope

Dental Membrane and Bone Graft Substitute Market: Segmentation

The global dental membrane and bone graft substitute industry is segmented based on product type, material type, end-users, and region.

Based on product type, the global dental membrane and bone graft substitute market is segmented into dental membrane (resorbable membranes and non-resorbable membranes) and bone graft substitutes (demineralized bone matrix, xenograft, allograft, autograft, and others). The bone graft substitutes segment is expected to dominate the market over the forecast period owing to increasing dental problems across the globe.

Based on material type, the global dental membrane and bone graft substitute industry is bifurcated into Hydrogel, Collagen, Polytetrafluoroethylene (PTFE), Human Cell Sources, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), and Others. The collagen segment is expected to hold the largest market share over the forecast period. The need for collagen membranes and graft substitutes is increased by the rise in periodontal disease cases, tooth loss, and implant placements. The extensive use of collagen is supported by its ability to promote bone and tissue healing.

Based on the end users, the global dental membrane and bone graft substitute market is bifurcated into hospitals, dental clinics, ambulatory surgical centers, and others. The dental clinics segment is expected to dominate the market during the forecast period. Due to their convenience and simple access to doctors, clinics are becoming more and more popular as the number of dental transplant surgeries conducted each year rises. These clinics are designed to provide same-day operations in a safer and faster manner than hospitals. Additionally, the industry is being driven by rising awareness about oral health.

Dental Membrane And Bone Graft Substitute Market: Regional Analysis

North America dominates the market over the projected period

North America is expected to dominate the global dental membrane and bone graft substitute market during the forecast period. The regional expansion is attributed to the advanced healthcare infrastructure. The adoption of cutting-edge dental regenerative products is facilitated by the presence of modern dental clinics and highly qualified personnel. In the United States and Canada, insurance coverage for dental operations promotes greater costs for patients.

Additionally, North American businesses are leading the way in the development of resorbable and bioactive graft materials, improving patient outcomes and diversifying their product lines. Innovation is fostered by cooperative efforts among research institutes, universities, and industry.

Dental Membrane and Bone Graft Substitute Market: Competitive Analysis

The global dental membrane and bone graft substitute market is dominated by players like:

• ACE Surgical Supply Co. Inc.
• Biohorizons Inc.
• Botiss Biomaterials GmbH
• Collagen Matrix Inc.
• CURASAN AG
• Dentsply Sirona
• Geistlich Pharma Ag
• KLS Martin Group
• Lifenet Health
• Medtronic
• NovaBone Products LLC
• RTI Surgical Holdings Inc.
• Salvin Dental Specialities Inc.
• Straumann Group
• Zimmer Biomet

The global dental membrane and bone graft substitute market is segmented as follows:

By Product Type

• Dental Membrane
  • Resorbable Membranes
  • Non-Resorbable Membranes
• Bone Graft Substitutes
  • Demineralized Bone Matrix
  • Xenograft
  • Allograft
  • Autograft
  • Others

By Material Type

• Hydrogel
• Collagen
• Polytetrafluoroethylene (PTFE)
• Human Cell Sources
• Hydroxyapatite (HA)
• Tricalcium Phosphate (TCP)
• Others

By End Users

• Hospitals
• Dental Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa